MobiHealth News November 21, 2022
Jessica Hagen

During a discussion at the HLTH 2022 conference, panelists said that companies need to refocus their business models due to an anticipated lack of funding.

There was a massive influx of capital provided to digital health companies in 2021, but there’s since been a contraction in the public market, with digital health funding decreasing. 

Still, with the increased investments seen last year, companies’ valuations rose and many gained unicorn status, a term given to privately held companies valued at a billion dollars or more.

But were companies valued at these high prices too early, allowing for unrealistic growth expectations?

“We don’t look for operators that are focused on that price at all. It’s how much capital do I need to...

Today's Sponsors

LEK
Teladoc Health
Amwell

Today's Sponsors

LEK
Teladoc Health

Today's Sponsor

Oliver Wyman

 
Topics: Conferences / Podcast, Digital Health, Investments, Technology, Trends
Digital health investment in 2023: 4 key things to know
Vial raises $67M for clinical trial tech and more digital health fundings
Global CIO: We must get digital investments right in 2023
Survey: Digital health investments will rely on ROI and clinical validation in 2023
Investments in Telehealth are Expected to Decrease